QA: Cymabay Therapeutics Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001042074_2023_Cymabay_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001042074, Cymabay Therapeutics Inc

  xvar xval
0 AssetsCurrent 138,073,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 701,000
3 remainder_Assets 3,078,000
4 LiabilitiesCurrent 15,441,000
5 LiabilitiesNoncurrent 30,000
6 remainder_Liabilities 90,227,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 25,403,446
9 ResearchAndDevelopmentExpense 67,496,277
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -11,805,491
13 remainder_ComprehensiveNetIncome -158,525
  yvar yval
0 Assets 141,852,000
1 Liabilities 105,698,000
2 Expenses 92,899,723
3 Revenues 0
4 StockholdersEquity 36,154,000
5 NetIncome -104,705,214
6 ComprehensiveNetIncome -104,784,476
7 BaseVar 176,206,870
8 EconomicCapitalRatiobeforeLimitedLiability -0.210
9 EconomicCapitalRatio 1.41

Edgar->Model Mapping

Feature Distribution

Change over Time